Yoga and Ayurveda, once seen primarily as wellness traditions, are now central to India's diplomatic playbook. The government is aggressively embedding these ancient systems into trade pacts, aiming to transform cultural exports into formal health services abroad. But behind the diplomatic fanfare, experts are sounding a cautious note: without ironclad standards and evidence, this ambitious global push could stumble.

Key facts

  • India signed FTAs with Oman (June 2026), New Zealand, and the EU (January 2026) that include traditional medicine provisions.
  • These deals ease licensing, set standards, and allow practitioner mobility for AYUSH and Yoga.
  • Foreign medical arrivals in India rose from 1.83 lakh in 2020 to 6.44 lakh in 2024.
  • 3,375 foreign nationals used Ayush visas between January 2023 and December 2025.

The Diplomatic Footprint

India's recent trade agreements read like a love letter to traditional medicine. The pact with Oman, operationalized in June 2026, marks what officials call the first comprehensive commitment on traditional medicine across all modes of supply. New Zealand's deal includes a dedicated annex covering Ayurveda, Yoga, and other systems, plus structured mobility pathways and special visa quotas. The EU agreement goes even further, permitting Indian AYUSH qualifications to be recognized in member states lacking their own regulatory frameworks—a significant door opener.

The Numbers Behind the Narrative

The government points to rising medical tourism numbers as proof of growing international interest. Foreign medical arrivals jumped to 6.44 lakh in 2024, up from 1.83 lakh in 2020. Top source countries include Bangladesh, Nepal, the UAE, the U.S., and Germany. The specialized Ayush visa, introduced in 2023, has drawn 3,375 foreign nationals so far. Education is another channel: 260 students from 32 countries are currently studying AYUSH in India under fellowship programs.

The Credibility Question

Yet for all the diplomatic energy, experts worry about the gap between recognition and real-world acceptance. Global healthcare markets are tightly regulated—patients demand safety, practitioners require quality training, and treatments need evidence. One senior official acknowledged the government doesn’t publish consolidated data on how many foreign patients specifically seek AYUSH treatments, making it hard to gauge actual demand. Without rigorous standards, credible regulation, and transparent data, even the most favorable trade terms may not translate into trust.

“Foreign medical arrivals rose from 1.83 lakh in 2020 to 6.44 lakh in 2024, as per our data. Bangladesh, Nepal, Sri Lanka, the United Arab Emirates, the United States, Germany, Russia, Malaysia, Mauritius and Saudi Arabia are among the important markets for AYUSH and Ayurveda treatment.”

The quote, from an AYUSH Ministry official, hints at the potential—but also the ambiguity. That 6.44 lakh figure represents all foreign medical arrivals, not just AYUSH patients. In the end, India’s ancient healing arts may travel far, but only if they carry credibility alongside culture.